Brand Name | Status | Last Update |
---|---|---|
rejuvesol | New Drug Application | 2023-02-14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 2 | 1 | — | — | — | 3 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 2 | 1 | — | — | — | 3 |
Progressive multifocal leukoencephalopathy | D007968 | EFO_0007455 | A81.2 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Aids-related complex | D000386 | EFO_0007137 | B20 | 2 | — | — | — | — | 2 |
Drug common name | Inosine |
INN | inosine |
Description | Inosine is a nucleoside that is formed when hypoxanthine is attached to a ribose ring (also known as a ribofuranose) via a β-N9-glycosidic bond. It was discovered in 1965 in analysis of RNA transferase.
Inosine is commonly found in tRNAs and is essential for proper translation of the genetic code in wobble base pairs.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O |
PDB | — |
CAS-ID | 58-63-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1556 |
ChEBI ID | 17596 |
PubChem CID | 6021 |
DrugBank | DB04335 |
UNII ID | 5A614L51CT (ChemIDplus, GSRS) |